Scott B. Ullem, CVP, Chief Financial Officer at Edwards Lifesciences Corp (EW), sold 161,400 shares at $89.22 ($14.3M) on 2023-05-10, disclosed to the SEC on 2023-05-11.
Scheduled sale ($14.3M) by CVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.36 | 64,119 | $5.7M | 39.6% |
| 2 | $88.36 | 64,119 | $5.7M | 39.6% |
| 3 | $89.22 | 16,581 | $1.5M | 10.4% |
| 4 | $89.22 | 16,581 | $1.5M | 10.4% |
| Total | $88.54 avg | 161,400 | $14.3M | 100% |
| Filing → |
| EW | SELL | 2025-12-09 | $650K | — | Filing → |
| EW | SELL | 2025-11-10 | $2.2M | — | Filing → |
| EW | SELL | 2025-05-09 | $1.7M | — | Filing → |